Biological Factors Associated With Subclinical Valvular Thrombosis

NCT03847948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2021-10-29

No results posted yet for this study

Summary

A prospective, multicentric cohort study including 166 patients with symptomatic aortic stenosis treated with transcatheter aortic valve implantation (TAVI).

\- The main objective is to determine whether the high residual platelet reactivity rates in patients undergoing TAVI is associated with the occurrence of clinical and / or subclinical prosthetic valve thrombosis measured by echocardiography and multi-slice computerized tomography

Conditions

  • Aortic Stenosis

Sponsors & Collaborators

  • FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOS

    collaborator OTHER
  • Instituto de Salud Carlos III

    collaborator OTHER_GOV
  • Hospital San Carlos, Madrid

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847948 on ClinicalTrials.gov